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Quercetin is one of the most abundant polyphenols found in fruits and vegetables. The ability of the gut
microbiota to metabolize quercetin has been previously documented; however, the effect that quercetin
may have on commensal gut microbes remains unclear. In the present study, the effects of quercetin on
the commensal gut microbes Ruminococcus gauvreauii, Biﬁdobacterium catenulatum and Enterococcus
caccae were determined through evaluation of growth patterns and cell morphology, and analysis of
genetic expression proﬁles between quercetin treated and non-treated groups using Single Molecule
RNA sequencing via Helicos technology. Results of this study revealed that phenotypically, quercetin did
not prevent growth of Ruminococcus gauvreauii, mildly suppressed growth of Biﬁdobacterium cat-
enulatum, and moderately inhibited growth of Enterococcus caccae. Genetic analysis revealed that in
response to quercetin, Ruminococcus gauvreauii down regulated genes responsible for protein folding,
purine synthesis and metabolism. Biﬁdobacterium catenulatum increased expression of the ABC transport
pathway and decreased metabolic pathways and cell wall synthesis. Enterococcus caccae upregulated
genes responsible for energy production and metabolism, and downregulated pathways of stress
response, translation and sugar transport. For the ﬁrst time, the effect of quercetin on the growth and
genetic expression of three different commensal gut bacteria was documented. The data provides insight
into the interactions between genetic regulation and growth. This is also a unique demonstration of how
RNA single molecule sequencing can be used to study the gut microbiota.
Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.
org/licenses/by/4.0/).1. Introduction
Quercetin is one of the most abundant polyphenols found in
fruits and vegetables with an estimated daily intake ranging from
0 to 30 mg/day [1e5]. The highest concentration of quercetin is
found in foods such as onions, berries, kale, and apples [1,2]. It is
known to be a potent anti-oxidant, a free radical scavenger of both
reactive oxygen and reactive nitrogen species, and binds with
transitional metal ions [2,6]. Over the last few decades, interest inman).
access article under the CC BY licethe functional properties of quercetin has increased as research
continues to demonstrate its ability to inhibit diseases such as
cardio-vascular disease, inﬂammation, cancer, diabetes, and obesity
[1,2,6].
Although a number of studies have provided evidence that
quercetin is beneﬁcial to human health, it unfortunately has low
oral bioavailability [7,8]. Quercetin is usually ingested in the form of
a b-glycoside, conjugated to a sugar moiety [2,9]. Glucose conju-
gated quercetin can be absorbed in the small intestine; however,
other conjugates cannot be absorbed and will be passed into the
colon [8,10]. It has been proposed that 90e95% of ingested poly-
phenols are not absorbed, and therefore enter the large intestinense (http://creativecommons.org/licenses/by/4.0/).
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ence of polyphenols in the colon, and their subsequent interaction
with the gut microbiota, may partially explain why eating a diet
high in fruits and vegetables reduces risk of gastro intestinal can-
cers and other age related diseases [11,12].
The ability of the gut microbiota to chemically modify poly-
phenols is well known. In fact, most metabolites of ingested poly-
phenols isolated from human blood and urine samples are
designated byproducts of colon metabolism [13]. For quercetin in
particular, studies have pre-established that non-absorbed quer-
cetin is transformed by the gut microbiota into phenolic acids
[6,8,12,14]. Research has found that the bacterial strains E. gilvus,
S. lutetiensis, E. coli, L. acidophilus, andW. confusa are able to degrade
quercetin to varying degrees [15] and that C. perfringens and
B. fragilis produce 3,4-dihydroxyphenylacetic acid from quercetin
[16,17]. These studies also demonstrate that the reported modula-
tions reduce quercetin's anti-oxidant properties [16,17]. Therefore,
it is well documented that the gut microbiota is able to affect the
chemical properties of quercetin [15]. However, the effect of quer-
cetin on the phenotype and genetic expression of the resident gut
bacteria is not as well characterized.
Until now, research studying the effects of quercetin on gut
microbes has been principally based on evaluating changes in cell
growth. Many of these studies use whole compounds that contain
multiple polyphenols, including quercetin, and involve the use of
pathogenic bacteria [17,18]. In one previous study, the effect of
quercetin on the growth of Biﬁdobacterium catenulatum (B. cat-
enulatum), Enterococcus caccae (E. caccae), and Ruminococcus
gauvreauii (R. gauvreauii) was tested, and the results provided
insight into how quercetin may inhibit or enhance growth of these
speciﬁc microbes [4]. This strategy is particularly meaningful
because it allows for the effect of quercetin to be determined
independently and on individual strains of bacteria without the
added factors that occur in a competitive environment. It is also
important that the strains tested in this study are in fact repre-
sentatives of a healthy human gut, and that each strain exhibits
multiple unique properties [19e25]. However, evaluating the
change in growth only partially describes how quercetin is able to
effect the bacterial cell. Due to the genetic differences between
B.catenulatum, E.caccae, and R.gauvreauii, it is possible that they
respond to quercetin in the same way phenotypically, but do so
through independent genetic pathways. Therefore, they would
exhibit the same phenotype, yet maintain different patterns of gene
expression which would be detectable at the mRNA level.
Recent advances in high-throughput sequencing technology
allows for the sequencing and identiﬁcation of mRNA at the single
molecule level, without the use of probes, ampliﬁcation or hy-
bridization procedures [26]. This new technology is able to detect
transcripts present at a low level, therefore more sensitive to small
changes, produces less background and has a higher degree of
reproducibility [26]. The application of single molecule sequencing
to study bacterial gene expression has provided a wealth of infor-
mation on bacterial gene regulation. This technology has been
previously used to analyze the transcriptome of soil microbial
communities [27], and mapped the transcriptome of Actinobacillus
pleuropneumoniae [28], and methicillin resistant Staphylococcus
aureus treated with ursolic acid and resveratrol [29].
In the current study, the effect of quercetin on B.catenulatum,
E.caccae, and R.gauvreauii was evaluated through both phenotypic
and genotypic analysis. The change in growth of these bacteria in
response to different doses of quercetin was ﬁrst documented over
24 h in order to generate growth curves. Images of each bacteria
grown with or without quercetin were captured using Scanning
Electron Microscopy (SEM) technology to check for any morpho-
logical differences. The genetic expression proﬁles for each straingrown with or without the addition of quercetin were then
generated using true single molecule RNA sequencing via Helicos
technology. The genotypic effect of quercetin on B.catenulatum,
E.caccae, and R.gauvreauii was determined by comparing the
expression proﬁles of quercetin-treated bacteria to the control. The
results of this analysis demonstrated that each strain responded to
quercetin through separate means, indicating that while the
phenotypic response may be the same, there is a difference at the
genetic level. This study provides a more in depth examination on
how quercetin may affect commensal gut microbes, and how the
use of advanced RNA sequencing technology can be applied to the
study of the gut microbiota.
2. Materials and methods
2.1. Culturing of anaerobic bacteria and broth preparation
Bacteria were ordered from the company Deutsche Sammlung
vonMikroorganismen und Zellkulturen GmbH (DSMZ) in Germany.
The following strains were ordered and used for all experiments:
Freeze Dried ampoule of 19829, Type strain; Ruminococcus gauv-
reauii CCRI-16110 (R. gauvreauii), Freeze Dried ampoule of 19114,
Type strain; Enterococcus caccae SS-1777 (E.caccae), Freeze Dried
ampoule of 16992, Type strain; Biﬁdobacterium catenulatum B669
(B.catenulatum). Frozen aliquots of bacteriawere recovered through
inoculation in strain speciﬁc broth, described below, and grown
overnight in the anaerobic chamber at 37 C. Each bacterial strain
was cultured and grown overnight sequentially at least twice prior
to use in order to ensure recovery from freezing.
All anaerobic broth was autoclaved under pressure at 120 C for
30 min. After autoclaving, the broth was boiled under negative
pressure using nitrogen gas for 10 min to remove any oxygen from
the solution [30,31]. The broth was then placed inside a Bactron
anaerobic chamber to cool overnight in oxygen free conditions. All
anaerobic broths were stored at room temperature in oxygen free
conditions until use and made fresh every two to three weeks. Each
strain was cultured and grown in the broth recommended by
DSMZ, all ingredients for which were purchased from Sigma-
Aldrich. R. gauvreauii was cultured in Peptone Yeast Glucose
broth (modiﬁed), B. catenulatum was cultured in Biﬁdobacterium
medium and E. caccae was cultured in Trypticase Soy Yeast Extract
medium [4].
2.2. The polyphenol quercetin
The polyphenol quercetin (Q4951-100G) was purchased from
the company Sigma-Aldrich and dissolved in DMSO to make a
working stock solution (freshly made for each experiment). For all
testing, the DMSO stock solution of quercetin was added to the
anaerobic broth at a volume of 10 mL DMSO stock solution per 5 mL
of anaerobic broth (all ﬁnal cultures contained 1% DMSO). Quer-
cetin was tested at a ﬁnal concentration of 12.5, 25, 50, and 75 mg/
mL for each bacterial strain. For each concentration tested the
polyphenol added to the anaerobic broth without addition of bac-
teria was used as a negative control and bacteria cultured in
anaerobic broth containing DMSO without polyphenol was used as
a positive control.
2.3. The effect of quercetin on growth of R. gauvreauii, E. caccae,
and B. catenulatum
All work for this experiment was performed in a Bactron
anaerobic chamber to ensure oxygen free conditions. Each bacterial
strain was maintained and experiments performed using their
speciﬁc anaerobic broth as described above. Anaerobic broth was
Peptone Yeast Glucose Broth (modiﬁed); Final pH 7.2
Ingredient Amount in 1 L dd H2O
Trypticase peptone 5.00 g
Peptone 5.00 g
Yeast extract 10.00 g
Beef extract 5.00 g
Glucose 5.00 g
K2HPO4 2.00 g
Tween80 1.00 mL
Cysteine-HCl x H2O 0.50 g
Resazurin 1.00 mg
Salt solution 40 mL
Haemin solution 10 mL
Vitamin K solution 0.20 mL
Biﬁdobacterium medium; Final pH 6.8
Ingredient Amount in 1 L dd H2O
Casein peptone tryptic digest 10.00 g
Yeast extract 5.00 g
Meat extract 5.00 g
Bacto Soytone 5.00 g
Glucose 10.00 g
K2HPO4 2.00 g
MgSO4 x 7 H20 0.20 g
Tween80 1.00 mL
NaCl 5.00 g
Cysteine-HCl x H2O 0.50 g
Resazurin 1.00 mg
Salt solution 40 mL
Salt solution
Ingredient Amount in 1 L dd H2O
CaCl2 x 2 H2O 0.25 g
MgSO4 x 7 H2O 0.50 g
K2HPO4 1.00 g
KH2PO4 1.00 g
NaHCO3 10.00 g
NaCl 2.00 g
Haemin solution
Ingredient Amount in 100 mL dd H2O
Haemin 50 mg dissolved in 1 mL of 1N NaOH
Trypticase Soy Yeast Extract Medium; Final pH 7.1
Ingredient Amount in 1 L dd H2O
Trypticase Soy broth 30.00 g
Yeast extract 3.00 g
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per tube. The tubes were sealed with a rubber septa and screw cap
lid, and stored at room temperature in the anaerobic chamber until
needed. (The hungate tubes, rubber septa and screw cap lids were
ordered from Chemglass.) All three strains of anaerobic bacteria
were grown overnight (16 h) at 37 C under anaerobic conditions in
5 mL of strain speciﬁc anaerobic broth.
To begin the experiment, each hungate tube containing pre-
aliquoted broth was injected with DMSO containing quercetin to
the desired ﬁnal concentration (1 mL needle and 25 gauge syringe).
The culture of bacteria grown overnight was diluted in their speciﬁc
broth to 0.5 McFarland units (MU) over the broth only read. Each
5 mL hungate tube containing the appropriate anaerobic broth and
the desired concentration of polyphenol was injected with 100 mL
of this culture using a 1 mL needle and a 25 gauge syringe. Each
hungate tube was brieﬂy vortexed after injection to ensure proper
distribution and the MUs for each culture were determined using a
densitometer (time 0 read). The cultures were then placed into the
anaerobic incubator set to 37 C. Each culture was removed from
the incubator at 4, 8, 12, and 24 h post inoculation, brieﬂy vortexed,and the MUs were measured using a densitometer. Each concen-
tration of quercetin tested was considered a set and consisted of six
hungate tubes of broth containing the desired polyphenol. Three
tubes were designated as a negative control, consisting of broth
containing the desired concentration of polyphenol only. The other
three tubes were designated as the experimental group, consisting
of broth containing polyphenol which were also inoculated with
bacteria.
The McFarland readings from each group were adjusted by
subtracting the broth control read. The adjusted numbers were
plotted in a growth curve as the change in MU over time. The
percent of control was calculated by dividing the MU of the
experimental group by the MU of the control and multiplying by
100. Time points 0, 4, and 8 h post inoculation are not considered
for percent of control for the strains R. gauvreauii and
B. catenulatum, and time points 0 and 4 h post inoculation are not
considered for percent of control for the strain E. caccae. This is
because the MU readings were too low at these time points for this
type of analysis. For each time point a 2-tailed, student t-test was
run to determine if the difference between the control and the
experimental groups was statistically signiﬁcant.
2.4. RNA extraction and RNA sequencing
The effects of quercetin on bacterial gene expression and regu-
lationwere determined throughmRNA analysis via SingleMolecule
RNA sequencing using Helicos technology (SeqLL, Boston, MA).
Total RNA was extracted from bacteria grown in the presence of
either quercetin or DMSO only, at the concentration of polyphenol
that was determined to have the most effect. R.gauvreauii was
cultured in the presence of 50 mg/mL of quercetin or 1% DMSO for
16 h. B. catenulatum was cultured in the presence of 50 mg/mL of
quercetin or 1% DMSO for 8 h. E. caccaewas cultured in the presence
of 25 mg/mL quercetin or 1% DMSO for 10 h. After growth, 15 mL of
these cultures were added to a 50 mL falcon tube and spun for
10 min at 5000 g to pellet the bacteria. Post centrifugation, the
supernatant was discarded, 1 mL of Trizol reagent was added, and
the pellet/Trizol mix was vortexed to ensure homogenization.
These samples were then frozen and stored at 80 C until needed.
Prior to RNA sequencing, an RNA extraction was performed
using the following Zymo Direct-zol RNAMiniprep protocol: 250 mL
of Trizol was added to 100 mL of each sample stored in Trizol
(described above). Next, 350 mL of pure ethanol was added directly
to each sample and homogenized. The sample/ethanol mixture was
then loaded into the Zymo-Spin II C column and centrifuged for 30 s
at 16000 g. After centrifugation, the column was washed with
400 mL of RNA wash buffer and then centrifuged for another 30 s.
Then, 80 mL of DNase I reaction mixture (5 mL DNAse I and 75 mL of
DNA digestion buffer) was added and the sample incubated at 25 C
for 15 min. Next, 400 mL of Direct-zol RNA prewash was applied to
the column, centrifuged for 30 s and the ﬂow through was dis-
carded. This step was repeated a second time. Then, 700 mL of RNA
wash buffer was added to each column and centrifuged for 2 min,
repeated twice. The column was transferred to an RNase free tube,
30 mL of RNase free water was added, and was centrifuged for 30 s.
The ﬁnal product was stored at 80 C until needed.
2.5. RNA sequencing data analysis
Single molecule RNA sequencing was carried out in a Helicos
sequencer by the company SeqLL (Boston, MA). In order to quantify
the gene expression of each bacterial strain through its treatment,
the full assembled genomes were downloaded from the National
Center of Biological Information (NCBI http://www.ncbi.nlm.nih.
gov/nuccore/NC_013198) [32]. Then, the reads of each sample
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order to increase the matching speciﬁcity, reads that were aligned
to multiple locations were assigned to their corresponding best
match. In this way, the genes are depicted by their number of
unique reads for each sample. Due to the different levels of abun-
dance through the samples, they were ﬁrst normalized by their
abundance and length using the RPKM [34] metric (reads per kilo
base of mapped reads). Finally, the gene expression levels were
computed by the log transformation of the RPMK abundances with
respect to each control, log 2 (RPKM[sample]/RPKM[control]). For
analytic purposes, genes with less than 50 reads total were not
considered. The fold change in expression for each gene was
determined through comparison of the experimental group
(quercetin treated) to the control group (DMSO only treated). Any
gene that had a higher number of reads compared to the DMSO
only control was considered upregulated and, conversely, any gene
that had a lower number of reads was considered downregulated.
2.6. Images of bacteria captured using SEM technology
Images of each bacterial strain treated with either quercetin or
DMSO were captured using SEM technology to analyze cell
morphology. To start, R. gauvreauii was cultured in 25 mL of
Peptone Yeast Glucose broth in the presence of 50 mg/mL of quer-
cetin or 1% DMSO for 16 h. B. catenulatumwas cultured in 25 mL of
Biﬁdobacterium broth in the presence of 50 mg/mL of quercetin or
1% DMSO for 8 h. E. caccaewas cultured in 25 mL of Trypticase Soy
Yeast Extract broth the presence of 25 mg/mL quercetin or 1% DMSO
for 10 h.
After the growth period, the bacteria were spun down at 5 g for
5 min to condense the culture, and the supernatant was discarded.
In the anaerobic chamber, the remaining pellet was vortexed and
20 mL of bacteria were pipetted onto an acetone cleaned 12 mm
Micro-cover glass slide (Thermo Scientiﬁc, Portsmouth NH, USA).
The bacteria were allowed to incubate on the slide for 30 min to
allow for proper adhering. Afterwards, 50 mL of 2.5% glutaraldehyde
(Electron Microscopy Sciences, Hatﬁeld PA, USA) was added to ﬁx
the cells for 30 min. The samples were then rinsed twice for 30 min
each with 2e3 mL of the 0.1 M imidazole, (Electron Microscopy
Sciences, Hatﬁeld PA, USA), followed by 30min intervals each of 50,
80, 90% ethanol (The Warner-Graham Company, Cockeysville, MD,
USA), at 2e3 mL each. The samples were then washed and held
three times with 2 mL of 100% ethanol before being critically point
dried. The samples were stacked in a wire basket, separated by
cloth, and placed in a Critical Point Drying Apparatus, (Denton
Vacuum, Inc, Cherry Hill, NJ, USA), using liquid carbon dioxide
(Welco Co, Allentown PA, USA) for approximately 20 min. The
samples were mounted on stubs and sputter gold coated for 1 min
(EMS 150R ES, EM Sciences, Hatﬁeld, PA). Samples were then
viewed with a FEI Quanta 200 F Scanning Electron Microscope,
(Hillsboro, OR, USA) with an accelerating voltage of 10 KV in high
vacuum mode.
3. Results
3.1. Effect of quercetin on the growth and morphology of
R. gauvreauii, B. catenulatum and E. caccae
R. gauvreauii, B. catenulatum and E. caccae were cultured in
strain speciﬁc broth containing different concentrations of quer-
cetin. Overall growth of each culture was measured in MUs at 0, 4,
8, 12, and 24 h post inoculation using a densitometer. The pheno-
typic effects of quercetin on R. gauvreauii, B. catenulatum and
E. caccae was examined by comparing the rate and pattern of
growth for cultures treated with increasing concentrations ofquercetin to the control group containing no polyphenol.
At zero and 24 h post inoculation there was no signiﬁcant dif-
ference (p > 0.05) between the control and cultures of R. gauvreauii
grown in the presence of quercetin at any concentration (Fig.1A). At
8 h post inoculation, there was a signiﬁcant increase in growth for
R. gauvreauii treated with either 75, 50, or 25 mg/mL quercetin ac-
cording to a 2-tailed, student t-test (Fig. 1A). However, the MU
readings at this time point were markedly low: 0.40 MU for 75 mg/
mL quercetin, 0.63 MU for 50 mg/mL quercetin, 0.33 MU for 25 mg/
mL quercetin, and only 0.01 MU for the control, making them un-
reliable. Therefore, it is misleading to say this difference is actually
signiﬁcant. At 12 and 24 h post inoculation there was no statistical
difference in growth between any concentration of quercetin and
the control group. This is best illustrated in the ﬁgure showing
percent of control, where growth ranges from 90.3%, for 75 mg/mL
of quercetin to 106.5%, for 50 mg/mL of quercetin at the 12 h time
point (Fig. 1B). Using SEM, whether or not quercetin had an effect
on the overall morphology of R. gauvreauii was determined. There
was no noticeable difference in size or cell shape for R. gauvreauii
treated with 50 mg/mL of quercetin (Fig. 1C and D) compared to that
of the control (Fig. 1E and F) at either 10,000 or 25,000 times
magniﬁcation.
For B. catenulatum, the addition of quercetin produced no real
inhibition of growth at 0, 4 and 8 h post inoculation (Fig. 2A).
However, at 12 h post inoculation there was a signiﬁcant reduction
in growth of B. catenulatum treated with all concentrations of
quercetin, except at the lowest concentration of 12.5 mg/mL. By 24 h
post inoculation, there was a signiﬁcant decrease in growth of
B. catenulatum for all concentrations of quercetin tested (Fig. 2A).
This suppression is best represented in the percent of control,
where groups treated with quercetin ranged from 87.9% of the
control for 25 mg/mL quercetin at the 12 h time point, to 95.5% of
control for 12.5 mg/mL quercetin at the 12 h time point (Fig. 2B). At
24 h post inoculation, the MU readings for B. catenulatumwere 9.13
MU for 75 mg/mL quercetin, 9.23 MU for 50 mg/mL quercetin, 9.3 for
25 mg/mL quercetin, 9.33MU for 12.5 mg/mL quercetin, and 9.87MU
for no quercetin. These reading indicated that the observed inhi-
bition of growthmay be dose dependent. The effect of quercetin on
cell morphology of B. catenulatum was determined using SEM
technology. There was no observed change in size or cell shape for
B. catenulatum treated with 50 mg/mL of quercetin (Fig. 2C and D)
compared to that of the control (Fig. 2E and F) at either 10,000 or
25,000 times magniﬁcation.
For E. caccae, treatment with quercetin produced no signiﬁcant
difference at time zero (Fig. 3A). However, at 4, 8, 12, and 24 h post
inoculation there was a statistically signiﬁcant inhibition of growth
for all concentrations, except for 12.5 mg/mL quercetin at 4 h and
50 mg/mL quercetin at 24 h post inoculation (Fig. 3A). At 24 h post
inoculation the MU readings for E. caccae were 4.77 MU for 75 mg/
mL quercetin, 5.03 MU for 50 mg/mL quercetin, 4.83 MU for 25 mg/
mL quercetin, 4.77 MU for 12.5 mg/mL quercetin, and 5.4 MU for no
quercetin. Because the severity of inhibition does not appear to
correlate with the dose, it is rational to conclude that inhibition is
not dose dependent. The suppression of growth due to quercetin is
best presented by the percent control, where at 8 h post inocula-
tion, all concentrations of quercetin had less than 90% growth, with
the lowest being 80.3% for 75 mg/mL quercetin and the highest
being 93.5% for 50 mg/mL quercetin (Fig. 3B). The percent of control
increases at 12 and 24 h post inoculation, indicating that E. caccae
was able to partially recover from the initial suppression. Using
SEM technology, changes in cell morphology due to the addition of
quercetin was examined. There was no observed change in size or
cell shape for E.caccae treated with 50 mg/mL of quercetin (Fig. 3C
and D) compared to that of the control (Fig. 3E and F) at either
10,000 or 25,000 times magniﬁcation.
Fig. 1. The effect of quercetin on the growth and morphology of R. gauvreauii. R. gauvreauii was inoculated and grown in the presence of increasing concentrations of quercetin
for 24 h. The MUs were measured using a densitometer at selected time points. The * mark indicates that the difference between the control and experimental groups was sta-
tistically signiﬁcant at that time point, according to a 2-tailed, student t-test (p < 0.05). A) The 24 h growth curve of R. gauvreauii cultured in Peptone Yeast Glucose broth (modiﬁed)
supplemented with increasing concentrations of quercetin. The dotted line represents bacteria grown without quercetin. Note that at the 8 h time point growth is signiﬁcantly
higher for all treated groups except 12.5 mg/mL, when compared to the control. B) The percent of control for each concentration of quercetin at 12 and 24 h post inoculation. C)
Image of R. gauvreauii treated with 50 mg/mL of quercetin captured using SEM technology, magniﬁed 10,000 times. D) SEM image of R. gauvreauii treated with 50 mg/mL quercetin,
magniﬁed 25,000 times. E) Image of R. gauvreauii treated with DMSO captured using SEM technology, magniﬁed 10,000 times. F) Image of R. gauvreauii treated with DMSO captured
using SEM technology, magniﬁed 25,000 times.
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The genetic expression proﬁle of R. gauvreauii grown in the
presence of 50 mg/mL of quercetin was assembled and compared to
the expression proﬁle of the control (DMSO treated). For
R. gauvreauii, 209 individual genes were identiﬁed. Of these genes,
only 26 were upregulated (12.4% of the total), 15 of which were
hypothetical proteins, and only nine produced a greater than 1.25
fold increase in expression (Table 1A). The other 183 genes iden-
tiﬁed were downregulated compared to the control (87.6% of the
total). Of the 183 downregulated genes, 32 produced a greater than
2.25 fold decrease in expression, 26 of which were hypothetical
proteins (Table 1B).
3.3. Genetic expression proﬁles of Biﬁdobacterium catenulatum
The genetic expression proﬁles of B. catenulatum grown in thepresence of 50 mg/mL of quercetin and compared to the expression
proﬁle of the control (DMSO treated). For B. catenulatum treated
with quercetin, 745 genes were identiﬁed. Out of the 745 genes,
only 170 were upregulated (22.8% of total), 67 of which were
conserved hypothetical proteins and 14 of which were hypothetical
proteins. Only 63 genes had a greater than 1.25 fold increase in
expression, and only 19 had a greater than 1.5 fold increase in
expression compared to the control (Table 2A). Of the genes iden-
tiﬁed a total of 575 were downregulated (77.2% of total), with 417
having a greater than 1.25 fold decrease in expression. There were
32 genes identiﬁed that had a greater than 2.5 fold decrease in
expression, 13 of which were hypothetical or conserved hypothet-
ical proteins (Table 2B).
3.4. Genetic expression proﬁles of Enterococcus caccae
The genetic expression proﬁles of E. caccaewere cultured in the
Fig. 2. The effect of quercetin on the growth of B. catenulatum. B. catenulatumwas inoculated and grown in the presence of increasing concentrations of quercetin for 24 h. The
MUs were measured using a densitometer at selected time points. The * mark indicates that the difference between the control and experimental groups was statistically signiﬁcant
at that time point, according to a 2-tailed, student t-test (p < 0.05). A) The 24 h growth curve of B. catenulatum cultured in Biﬁdobacterium medium supplemented with increasing
concentrations of quercetin. The dotted line represents bacteria grownwithout quercetin. Note that at the 12 and 24 h time points, growth was signiﬁcantly inhibited for all treated
groups compared to the control except for 12.5 mg/mL at 12 h. B) The percent of control for each concentration of quercetin at 12 and 24 h post inoculation. C) Image of
B. catenulatum treated with 50 mg/mL of quercetin captured using SEM technology, magniﬁed 10,000 times. D) Image of B. catenulatum treated with 50 mg/mL quercetin captured
using SEM technology, magniﬁed 25,000 times. E) Image of B. catenulatum treated with DMSO captured using SEM technology, magniﬁed 10,000 times. F) Image of B. catenulatum
treated with DMSO captured using SEM technology, magniﬁed 25,000 times.
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proﬁle of the control (DMSO treated). For E. caccae treated with
quercetin, 759 genes were identiﬁed. Of these genes, 413 were
upregulated (54.4% of total), 149 of which were hypothetical pro-
teins. Out of these upregulated genes, 48 produced a greater than
1.25 fold increase in expression and nine produced a greater than
1.5 fold increase in expression (Table 3A). There were 346 genes
found to be downregulated in response to quercetin (45.6% of total),
139 of which were hypothetical proteins. Out of the downregulated
genes, 78 had a greater than 1.25 fold decrease in expression, and
26 had a 1.5 fold decrease in expression compared to the control
(Table 3B).
4. Discussion
Our results demonstrated that quercetin treatment had nosubstantial effect on the growth of R. gauvreauii (Fig. 1A and B). The
only statistically signiﬁcant effect was an increase in growth at the
8 h time point; however, this is likely to be artefact due to low MU
readings. Interestingly, at a concentration of 75 mg/mL of quercetin,
R. gauvreauii growth only reached 90.3% of control at 12 h and 92.1%
of control at 24 h (Fig.1B). While this differencewas not statistically
signiﬁcant according to a 2-tailed, student t-test, it was perceptible,
and indicated that the addition of quercetin may not be immaterial.
Based on this observation, we hypothesized that even though there
is no real phenotypic change, the effects of quercetin on
R. gauvreauii would be evident at the genotypic level.
For R. gauvreauii treated with quercetin, 209 individual genes
were identiﬁed and their levels of expressionwere compared to the
DMSO only control. Of these 209 genes, only 25 were upregulated
in response to quercetin, and only nine of these had a greater than
1.25 fold increase in expression (Table 1A). The ﬁve genes with the
Fig. 3. The effect of quercetin on the growth of E.caccae. E. caccae was inoculated and grown in the presence of increasing concentrations of quercetin for 24 h. The MUs were
measured using a densitometer at selected time points. The * mark indicates that the difference between the control and experimental groups was statistically signiﬁcant at that
time point, according to a 2-tailed, student t-test (p < 0.05). A) The 24 h growth curve of E.caccae cultured in Trypticase Soy Yeast Extract medium supplemented with increasing
concentrations of quercetin. The dotted line represents bacteria grown without quercetin. Note that growth was signiﬁcantly inhibited by all concentrations of quercetin at 4, 8, 12,
and 24 h post inoculation compared to the control except for 50 mg/mL at 24 h. B) The percent of control for each concentration of quercetin at 8, 12, and 24 h post inoculation. C)
Image of E. caccae treated with 25 mg/mL of quercetin captured using SEM technology, magniﬁed 10,000 times. D) Image of E. caccae treated with 25 mg/mL quercetin captured using
SEM technology, magniﬁed 25,000 times. E) Image of E. caccae treated with DMSO captured using SEM technology, magniﬁed 10,000 times. F) Image of E. caccae treated with DMSO
captured using SEM technology, magniﬁed 25,000 times.
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an observed 1.5e2.0 fold change (Table 1A). Since they are listed as
hypothetical proteins and their functions have not yet been
deﬁned, not much can be determined from this data. However, it is
remarkable to ﬁnd a group of them together. It is possible that they
belong to a single system that has not yet been identiﬁed, or they
maywork together to perform a speciﬁc function in R. gauvreauii. It
is also quite possible that they are unrelated.
There were only two other genes identiﬁed that had a greater
than 1.25 fold increase in expression in response to quercetin: a
peptide ABC transporter permease and a secondary thiamine-phosphate synthase, both with a fold increase of 1.4 (Table 1A).
The ABC transporter permease is a key player in the ABC trans-
porter system, a well-deﬁned system of cellular transporters
ubiquitous in bacteria [35]. The ABC transporter system is respon-
sible for the transport of molecules into and out of the cell and is a
contributing factor in antibiotic resistance [35,36]. The thiamine
phosphate synthase is a critical component of thiamine (Vitamin
B1) synthesis [37]. Thiamine is essential for metabolism and is
crucial for all life forms, including R. gauvreauii [37]. However, since
the increase in expression for both of these genes is marginal and
they are not related, it is unclear whether this increase is due to
Table 1A
Ruminococcus gauvreauii genes upregulated in response to quercetin.
Gene ID Description Fold: Description of function
H604_RS0101225 Hypothetical protein 2.0 Unknown
H604_RS22190 Hypothetical protein 1.9 Unknown
H604_RS19870 Hypothetical protein 1.5 Unknown
H604_RS0101030 Hypothetical protein 1.5 Unknown
H604_RS0100655 Hypothetical protein 1.5 Unknown
H604_RS0100880 Peptide ABC transporter permease 1.4 Molecular translocation
H604_RS0100950 Secondary thiamine-phosphate synthase 1.4 Thiamine biosynthesis
H604_RS0101195 Hypothetical protein 1.3 Unknown
H604_RS0100515 Hypothetical protein 1.3 Unknown
Table 1B
Ruminococcus gauvreauii genes downregulated in response to quercetin.
Gene ID Description Fold ; Description of function
H604_RS0100305 Purine-nucleoside phosphorylase 4.1 Purine synthesis
H604_RS0100530 Nucleotide exchange factor GrpE 3.5 Protein folding
H604_RS0100265 Phosphonoacetaldehyde hydrolase 3.3 Metabolism
H604_RS0100590 Hypothetical protein 3.2 Unknown
H604_RS0100195 Hypothetical protein 3.2 Unknown
H604_RS0100630 Hypothetical protein 2.9 Unknown
H604_RS0100225 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase 2.9 Metabolism
H604_RS0100435 Magnesium chelatase 2.9 Metabolism
H604_RS0100645 Inositol 2-dehydrogenase 2.8 Metabolism
H604_RS0100755 DNA ligase (NAD(þ)) LigA 2.8 DNA Replication
H604_RS0100130 Molecular chaperone DnaJ 2.8 Protein folding
H604_RS0100350 Iron transporter FeoA 2.8 Iron uptake
H604_RS0101105 Hypothetical protein 2.7 Unknown
H604_RS0100520 Molecular chaperone DnaJ 2.6 Protein folding
H604_RS19810 Hypothetical protein 2.6 Unknown
H604_RS0100810 Hypothetical protein 2.6 Unknown
H604_RS0100450 Methyltransferase 2.5 Methylation
H604_RS0100235 Hypothetical protein 2.5 Unknown
H604_RS0100410 Molecular chaperone GroEL 2.5 Protein folding
H604_RS0100180 Phosphoribosylaminoimidazolesuccinocarboxamide synthase 2.4 Purine synthesis
H604_RS0100525 Molecular chaperone DnaK 2.4 Protein folding
H604_RS0100025 Hypothetical protein 2.4 Unknown
H604_RS0100475 Holliday junction DNA helicase 2.4 DNA repair
H604_RS0100815 ABC transporter 2.4 Molecular translocation
H604_RS0101070 Oxidoreductase 2.4 Metabolism
H604_RS0100820 Ribokinase 2.4 Metabolism
H604_RS19825 Hypothetical protein 2.3 Unknown
H604_RS0100455 Hypothetical protein 2.3 Unknown
H604_RS0100945 SDR family oxidoreductase 2.3 Metabolism
H604_RS0100090 Inositol 2-dehydrogenase 2.3 Metabolism
H604_RS0100170 Adenylosuccinate lyase 2.3 Purine synthesis
H604_RS0101085 Hypothetical protein 2.3 Unknown
Table 2A
Biﬁdobacterium catenulatum genes upregulated in response to quercetin.
Gene ID Description Fold : Description of function
BBCT_0715 Hypothetical protein 2.3 Unknown
BBCT_1466 Conserved hypothetical protein 2.1 Unknown
BBCT_0472 Hypothetical protein 2.0 Unknown
BBCT_0202 Conserved hypothetical protein 1.9 Unknown
BBCT_0743 Conserved hypothetical protein 1.8 Unknown
BBCT_0807 Hypothetical protein 1.7 Unknown
BBCT_0952 Conserved hypothetical protein 1.7 Unknown
BBCT_0948 Conserved hypothetical protein 1.7 Unknown
BBCT_0697 ABC transporter permease component 1.6 Molecular translocation
BBCT_1237 Putative lipoprotein signal peptidase 1.6 Protein secretion
BBCT_1357 Putative adenine glycosylase 1.6 DNA repair
BBCT_0629 Truncated conserved hypothetical protein 1.6 Unknown
BBCT_1709 Ribonuclease P 1.6 Transcription
BBCT_0642 ABC transporter ATP-binding component 1.5 Molecular translocation
BBCT_0076 Thiazole synthase 1.5 Thiamine biosynthesis
BBCT_0091 Transcriptional regulator 1.5 Transcription
BBCT_1210 Phospho-N-acetylmuramoyl-pentapeptide- transferase 1.5 Cell wall synthesis
BBCT_1642 Sugar ABC transporter permease component 1.5 Molecular translocation
BBCT_1113 Putative multidrug transport protein 1.5 Molecular translocation
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Table 2B
Biﬁdobacterium catenulatum genes downregulated in response to quercetin.
Gene ID Description Fold; Description of function
BBCT_1455 L-ribulose-5-phosphate 4-epimerase 5.3 Metabolism
BBCT_1640 Hypothetical protein 4.6 Unknown
BBCT_1163 Conserved hypothetical protein 4.4 Unknown
BBCT_0095 Putative glutaredoxin 4.0 Stress response
BBCT_1543 UDP-galactopyranose mutase 3.9 Cell wall synthesis
BBCT_1330 Transposase 3.7 Stress response
BBCT_1179 Nicotinate-nucleotide pyrophosphorylase 3.4 Metabolism
BBCT_0040 Hypothetical protein 3.3 Unknown
BBCT_0142 Putative UDP-galactopyranose mutase 3.3 Cell wall synthesis
BBCT_1080 Conserved hypothetical protein 3.2 Unknown
BBCT_1078 Conserved hypothetical protein 3.2 Unknown
BBCT_1062 DNA ligase 3.1 DNA repair
BBCT_1329 Putative transposase 3.1 Stress response
BBCT_0569 Conserved hypothetical protein 3.1 Unknown
BBCT_0098 Transcriptional regulator 3.0 Transcription
BBCT_0272 Conserved hypothetical protein 2.9 Unknown
BBCT_1117 Conserved hypothetical protein 2.8 Unknown
BBCT_0034 Putative phosphoprotein phosphatase 2.8 Metabolism
BBCT_1116 Deoxyuridine 5'-triphosphate nucleotidohydrolase 2.8 Thymidine synthesis
BBCT_1594 Chaperone GrpE 2.8 Protein folding
BBCT_0011 Hypothetical protein 2.6 Unknown
BBCT_0954 Conserved hypothetical protein 2.6 Unknown
BBCT_1033 Arginine repressor 2.6 Transcription
BBCT_1380 Conserved hypothetical protein 2.6 Unknown
BBCT_1369 Conserved hypothetical protein 2.6 Unknown
BBCT_0203 Conserved hypothetical protein 2.6 Unknown
BBCT_0008 Glutamate dehydrogenase 2.5 Metabolism
BBCT_0990 Ribosome recycling factor 2.5 Protein synthesis
BBCT_1001 Gamma-glutamyl phosphate reductase 2.5 Metabolism
BBCT_1563 Putative DNase 2.5 DNA repair
BBCT_1473 ATP synthase gamma subunit 2.5 ATP synthesis
BBCT_1011 Carbohydrate kinase 2.5 Metabolism
Table 3A
Enterococcus caccae genes upregulated in response to quercetin.
Gene ID Description Fold : Description of function
UC7_RS13225 Hypothetical protein 2.0 Unknown
UC7_RS16330 Acyl carrier protein 1.7 Fatty acid synthesis
UC7_RS12845 RpiR family transcriptional regulator 1.6 Metabolism
UC7_RS13295 Cold-shock protein 1.6 Stress response
UC7_RS13975 Hypothetical protein 1.6 Unknown
UC7_RS16530 Hypothetical protein 1.5 Unknown
UC7_RS13120 Hypothetical protein 1.5 Unknown
UC7_RS16155 Hypothetical protein 1.5 Unknown
UC7_RS16200 4-oxalocrotonate tautomerase family enzyme 1.5 Metabolism
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There were 32 genes identiﬁed which had a greater than 2.25
fold decrease in expression in response to quercetin (Table 1B).
Notably, R. gauvreauii treated with quercetin resulted in the
downregulation of three genes involved in purine synthesis; a
purine-nucleoside phosphorylase gene with a 4.1 fold decrease, a
phosphoribosylaminoimidazolesuccinocarboxamide (SAICAR)
synthase gene with a 2.4 fold decrease, and an adenylosuccinate
lyase gene with a 2.4 fold decrease (Table 1B). The purine-
nucleoside phosphorylase is ubiquitous in bacteria and involved
in purine synthesis through the recovery of purine bases from both
purineribo-nucleosides and dexoyribo-nucleosides [38]. Both the
SAICAR synthase and the adenylosuccinate lyase are involved in de
novo purine synthesis [39,40]. A downregulation of these genes
indicates that either quercetin was directly inhibiting purine syn-
thesis, or less purines were needed at that time. This would occur if
there was a decrease in DNA replication or transcription, both of
which typically require purine synthesis.
Also of interest was the downregulation of ﬁve genes involved in
protein folding (Table 1B). These were the nucleotide exchangefactor GrpE with a 3.5 fold decrease, twomolecular chaperone DnaJ
genes with a 2.8 and 2.6 fold decrease respectively, a molecular
chaperone GroEL gene with a 2.5 decrease, and the molecular
chaperone DnaK with a 2.4 fold decrease (Table 1B). These ﬁve
genes code for protein chaperones, which ultimately function to
maintain cellular proteostasis [41] through the prevention of pro-
tein aggregation and the refolding of misfolded proteins [42]. A
downregulation of the chaperone pathway would indicate that
there is either less protein being made or that misfolded proteins
are being produced and not corrected.
Whether the ability of R. gauvreauii to maintain normal growth
resulted from genetic upregulation or downregulation remains
unclear. Nevertheless, there was a substantial disparity between
the number of genes upregulated and the number downregulated.
Of the 209 identiﬁed genes, 151 had a greater than 1.25 fold
decrease in expression, which is over 16 times more than the
number upregulated. This data indicated that R. gauvreauii may
counter-act quercetin through a decrease in gene expression. The
change in gene expression did not produce any changes in the size
or shape of the bacteria, according to images captured using SEM
Table 3B
Enterococcus caccae genes downregulated in response to quercetin.
Gene ID Description Fold ; Description of function
UC7_RS14840 Hypothetical protein 1.9 Unknown
UC7_RS16020 Hypothetical protein 1.9 Unknown
UC7_RS15835 Peroxiredoxin 1.7 Stress response
UC7_RS14150 Serine hydrolase 1.7 Metabolism
UC7_RS13955 Protein-(glutamine-N5) methyltransferase_ release factor-speciﬁc 1.7 Methylation
UC7_RS11045 Hypothetical protein 1.6 Unknown
UC7_RS15880 Hypothetical protein 1.6 Unknown
UC7_RS13990 Hypothetical protein 1.6 Unknown
UC7_RS11475 Hypothetical protein 1.6 Unknown
UC7_RS13720 Hypothetical protein 1.6 Unknown
UC7_RS14195 PTS beta-glucoside transporter subunit EIIBCA 1.6 Sugar transport
UC7_RS13055 Amidophosphoribosyltransferase 1.6 Purine synthesis
UC7_RS11300 Hypothetical protein 1.5 Unknown
UC7_RS14385 Hypothetical protein 1.5 Unknown
UC7_RS11920 DNA topoisomerase IV subunit B 1.5 DNA replication
UC7_RS12280 Hypothetical protein 1.5 Unknown
UC7_RS11280 Hypothetical protein 1.5 Unknown
UC7_RS14715 Hypothetical protein 1.5 Unknown
UC7_RS15605 Hypothetical protein 1.5 Unknown
UC7_RS14845 Spermidine/putrescine ABC transporter spermidine/putrescine-binding protein 1.5 Molecular transport
UC7_RS13770 CAAX amino protease 1.5 Protein transport
UC7_RS15260 Hypothetical protein 1.5 Unknown
UC7_RS15895 D-alanyl-lipoteichoic acid biosynthesis protein DltD 1.5 Cell wall synthesis
UC7_RS13735 Hypothetical protein 1.5 Unknown
UC7_RS14935 Ribosomal RNA large subunit methyltransferase A 1.5 Methylation
UC7_RS11075 Holliday junction resolvase RecU 1.5 DNA repair
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Ultimately, R. gauvreauii was able to maintain a normal
phenotype under all concentrations of quercetin that were tested.
Therefore, it is reasonable to conclude that any changes in genetic
expression due to the addition of quercetin are both deliberate and
necessary to sustain a normal growth pattern. These results indi-
cate that in response to quercetin, R. gauvreauii upregulates a group
of hypothetical proteins with unknown functions, and down-
regulates multiple genes responsible for metabolism, purine syn-
thesis, and protein folding (Tables 1A and 1B).
Primary experimental results demonstrated that quercetin was
able to statistically suppress growth of B. catenulatum at 12 and 24 h
post inoculation (Fig. 2A and B). Although it was not a substantial
reduction, with the percent ranging from 87.9 to 95.5% of control
(Fig. 2B), and the detected phenotypic change was small, it pro-
vided evidence that the addition of quercetin is not inconsequen-
tial. Based on this conclusion, we hypothesized that the underlying
source of this phenotypic change would be detectable at the
genotypic level.
Treatment of B. catenulatumwith quercetin resulted in a greater
than 1.5 fold increase in expression for 19 individual genes
(Table 2A). Markedly, the eight genes with the highest increase in
expression were categorized as either hypothetical or conserved
hypothetical proteins, ranging from a 1.7e2.3 fold increase
(Table 2A). This is similar to the pattern of upregulation for
R. gauvreauii treated with quercetin (Table 1A). It is possible that
both sets of proteins are similar, but since the functions of these
genes are unknown, no conclusion can be drawn.
Besides the hypothetical or conserved hypothetical proteins,
there were four genes upregulated that are involved in molecular
translocation (Table 2A). These four are: the ABC transporter
permease component, with a 1.6 fold increase, as well as the ABC
transporter ATP-binding component, the sugar ABC transporter
permease component, and the putative multidrug transport pro-
tein, with a 1.5 fold increase in expression (Table 2A). As mentioned
previously, the ABC transporter system is a well-deﬁned system of
cellular transporters, ubiquitous in bacteria, responsible for the
transport of molecules into and out of the cell [35]. They are alsoinvolved in antibiotic resistance since they can be used by bacteria
to efﬂux unwanted molecules from their interior [35,36]. It is
possible B. catenulatum responds to quercetin by attempting to
remove the substrate, which would explain the upregulation of
these particular genes. Although each of these genes presented
with a less than 2 fold increase, it may be signiﬁcant that 21% of
upregulated genes with over a 1.5 fold increase are identiﬁed as
transporters.
There were 32 genes identiﬁed that had a greater than 2.5 fold
decrease in expression in response to quercetin for B. catenulatum.
Of these genes, six were associated with various pathways in
metabolism, indicating that overall cellular function is decreased
(Table 2B). This observation is further supported by the fact that the
gene with the most reduction was the L-ribulose-5-phosphate 4-
epimerase, which presented a 5.3 fold decrease in activity. The
epimerase has been demonstrated to catalyze the interconversion
of L-ribulose 5-phosphate and D-xylulose 5-phosphate, the last step
of L-arabinose conversion [43,44]. L-arabinose is used by bacteria as
a carbon source to produce energy [45]. Therefore, a decrease in L-
ribulose-5-phosphate 4-epimerase would correlate to a decrease in
catabolism and energy production.
Interestingly, there was also a decrease in the UDP-
galactopyranose mutase and a putative UDP-galactopyranose
mutase genes, with a 3.9 and 3.3 fold decrease respectively
(Table 3B). The UDP-galactopyranosemutase is an essential enzyme
that converts UDP-Galp to UDP-Galf, a main component of the
bacterial cell wall and cell surface [46]. It would reason that if
quercetin inhibits growth, less energy would be required with a
decreased demand for cell wall proteins. It is also possible that
quercetin limits cell wall synthesis, which reduces the ability of the
bacterial cell to grow and, ultimately, to divide. Of note, the addition
of quercetin did not affect morphology of B. catenulatum according
to analysis of images captured using SEM technology (Fig. 2CeF).
In the end, growth of B. catenulatum was suppressed under all
concentrations of quercetin tested at 24 h post inoculation.
Therefore, it is rational to conclude that any changes in genetic
expression due to the addition of quercetin, while deliberate, are
insufﬁcient to completely counteract the inhibitory effects. Our
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increasing ABC transport, possibly in an attempt to remove the
polyphenol from the cell, and the decrease of multiple metabolic
pathways and cell wall synthesis. However, whether the change in
regulation of these genes is the cause or the result of suppressed
growth due to the addition of quercetin remains unclear.
Experimental results demonstrated that quercetin effectively
inhibited growth of E. caccae at 4,8,12, and 24 h post inoculation.
While suppressionwas only mild to moderate, ranging from 80.3 to
93.5% of control, it was continuous and E. caccae was unable to
counteract the effect. Since there was an observed phenotypic ef-
fect of quercetin on E. caccae, it is hypothesized that the underlying
cause of this phenotypic change would be detectable at the geno-
typic level.
For E. caccae treated with quercetin, there were only nine genes
that had a greater than 1.5 fold increase in expression, ﬁve of which
were identiﬁed as hypothetical proteins (Table 3A). Disregarding
the ﬁve hypothetical proteins, of the four remaining, two of the
upregulated genes were involved in metabolism, more speciﬁcally
in energy production. The ﬁrst gene, an RpiR family transcriptional
regulator, was upregulated by 1.6 fold (Table 3A). Although this
gene codes for a transcriptional element, it is listed as functioning
in metabolism because this family of regulators is responsible for
the transcription of genes involved in sugar catabolism [47]. The
second gene, a 4-oxalocrotonate tautomerase family enzyme, is
upregulated by 1.5 fold (Table 3A). This enzymes has the ability to
use aromatic hydrocarbons as a source of carbon and energy [48].
An upregulation of two individual genes involved in energy pro-
duction may explain why E. caccae is effected by quercetin but is
still able to maintain growth.
There were 26 genes identiﬁed that were downregulated for
E. caccae treatedwith quercetin. The genewith the largest decrease,
disregarding the hypothetical proteins, was a peroxiredoxin
(Table 3B). Peroxiredoxins are thiol-speciﬁc antioxidants that work
via peroxidase activity, are also thought to be involved in signal
transduction [49]. There was also a 1.7 fold decrease in the protein-
(glutamine-N5) methyltransferase, a release factor-speciﬁc gene
(Table 3B). Methyltransferases are enzymes that transfer methyl
groups to substrates. It has been previously demonstrated that N5-
methylation of the glutamine residue allows for the release of a
polypeptide during translation [50]. It is possible that these path-
ways were downregulated to conserve energy, or that the observed
decrease was due to a slower growth rate.
Interestingly, there was also a downregulation of two trans-
porter genes, a result which was also found in B. catenulatum
treated with quercetin. There is a 1.6 fold decrease in the PTS beta-
glucoside transporter subunit EIIBCA and a 1.5 fold decrease in the
spermidine/putrescine ABC transporter spermidine/putrescine-
binding protein (Table 3B). The spermidine/putrescine ABC trans-
porter spermidine/putrescine-binding protein is a system that
transports both the essential polyamines spermidine and putres-
cine into the cell [51]. The PTS beta-glucoside transporter subunit
EIIBCA is part of the carbohydrate phosphotransferase system
(PTS). This is a well-deﬁned system in bacteria that is responsible
for the uptake of sugar and carbohydrates into the cell [52]. For
E. caccae, it seems that there is an upregulation of catabolic path-
ways, yet a downregulation of sugar transport. This appears
counter-intuitive, but it is possible that with an absence of sub-
strate transport into the cell, pathways to use other sources of
carbon for energy would need to be upregulated to maintain
homeostasis.
Ultimately, the growth of E. caccae was suppressed due to the
addition of quercetin. However, SEM analysis revealed no changes
in cell morphology due to quercetin treatment (Fig. 3CeF). There-
fore it is logical to say that any changes in the pattern of geneticexpression due to the addition of quercetin were only able to
partially counteract any negative effects, or were ineffectual. These
results indicate that in response to quercetin, E. caccae upregulated
genes responsible for energy production and metabolism, and
downregulated pathways of stress response, translation, and sugar
transport.
Interestingly, each of the three bacterial strains tested respon-
ded differently to quercetin phenotypically. The addition of quer-
cetin did not prevent growth of R. gauvreauii, mildly suppressed the
growth of B. catenulatum, and inhibited growth of E. caccae with
mild to moderate results. Because each of the bacterial strains
tested is unique and contains different genes and regulatory ele-
ments, changes in their genetic expression cannot legitimately be
compared to each other. However, there are a few observations
regarding the genetic response of these strains to quercetin that
were noted.
Remarkably, all three strains had an upregulation of hypothet-
ical, or conserved hypothetical proteins. For R. gauvreauii, they
represented the top ﬁve genes upregulated, and for B. catenulatum,
the top eight genes coded for hypothetical proteins. However, un-
like R. gauvreauii and B. catenulatum, E. caccae did not have a group
of multiple hypothetical proteins at the top of its list. It is possible
that the absence of upregulated genes in this group was the reason
E. caccae was more susceptible to quercetin. Since the function of
the hypothetical genes is unknown, there is no way to determine if
this is truly the case. However, it is an interesting observation.
It was also noted that both R. gauvreauii and B. catenulatum had
an increase in an ABC transporter permease and upregulation of the
thiamine biosynthesis pathway. Conversely, neither of these were
increased by E. caccae. Furthermore, R. gauvreauii and
B. catenulatum also presented a more severe downregulation of
genes. For R. gauvreauii there was a 4.1 fold decrease in purine
nucleoside phosphorylase and for B. catenulatum there was a 5.3
fold decrease in 1-ribulose-epimerase. However, for E. caccae the
maximum downregulation was only 1.9 fold. It is possible that
these differences in the pattern of gene regulation are the reason
why E. caccae was unable to counteract quercetin to the same
extent as R. gauvreauii and B. catenulatum.
5. Conclusion
For the ﬁrst time, the effect of the polyphenol quercetin on the
growth and genetic expression of three different commensal gut
bacteria was documented. Interestingly, we found the growth
patterns differed in response to quercetin, with varying degrees of
inhibition observed. Through analysis of the resulting genetic
expression, we were able to determine which genes were upre-
gulated and downregulated for each bacteria. The pattern of gene
expression was consistent with the observed phenotype and pro-
vides insight into the interaction between genetic regulation and
growth. This is also a unique demonstration of how RNA single
molecule sequencing can be used to study the gut microbiota.
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